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Helicobacterpyloriand Dyspepsia
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University ofSydney, Penrith, New South Wales, Australia
It is clear that non-ulcer (orfunctional) dyspepsia is a heterogenous syndrome that includes a sub-
set ofpatients with unrecognized gastroesophageal reflux. Patient heterogeneity combined with
inadequate study methodology has led to enormous confusion in interpreting the relationship
between Helicobacter pylori and non-ulcer dyspepsia. The possibility that H. pylori is associated
with gastroesophageal reflux disease may explain, in part, the difficulty in establishing a link
between non-ulcer dyspepsia and H. pylorn infection. It is unclear whether the prevalence ofH.
pylori is increased in non-ulcer dyspepsia over and above the background population. H. pylori
does not appear to be linked to heartburn or other specific upper gastrointestinal tract symptoms.
The results oferadication trials in H. pylori-infected patients with non-ulcer dyspepsia have been
equivocal and generallyflawed. There is no doubt that H. pylori is not a sufficient cause ofnon-
ulcer dyspepsia, because it is well documented in the literature that dyspepsia can occur in the
absence ofinfection andinfection can occur in the absence ofsymptoms. Atthis stage, there is insuf-
ficient evidence to support the hypothesis that H. pylori is etiologically linked to non-ulcer dyspep-
sia, but data from well designed large randomized controlled trials of eradication therapy are
awaited with great interest.
INTRODUCTION
Definitions of dyspepsia have often
included upper abdominal as well as reflux
symptoms, which has led to considerable
confusion in the literature [1, 2]. In order
to try and clarify the situation, consensus-
based definitions have been developed.
The most widely accepted definition of
dyspepsia, commonly referred to as the
"Rome" definition, defines the condition
as chronic or recurrent pain or discomfort
centered in the upper abdomen [1]; it was
concluded that those with heartburn alone
or those in whom heartburn is the predom-
inant complaint are most likely to have
gastroesophageal reflux disease and
should not be labelled as having dyspep-
sia, although this is often ignored [1].
A vexing question is the relationship
between Helicobacter pylori gastritis and
dyspepsia. Only a minority with dyspepsia
have an obvious structural explanation
such as chronic peptic ulcer disease [1-3];
the remainder are generally labelled as
having non-ulcer (or functional) dyspep-
sia. While there is no dispute thatH. pylori
is causally linked to chronic peptic ulcer
disease, the association with non-ulcer
dyspepsia is highly controversial [3-6]. Of
course, non-ulcer dyspepsia is a very poor
term: it implies the presence of a disorder
based on the absence of a disease, namely
peptic ulcer. However, non-ulcer dyspep-
sia remains one of the most widely used
terms in practice. Here, the link between
non-ulcer dyspepsia and reflux and their
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Figure 1. Distribution of upper abdominal pain (dyspepsia) and heartburn in a pop-
ulation-based study from the United Kingdom. From Reference [7] with permission.
association with H. pylori infection will be
critically reviewed.
HOW MUCH OF DYSPEPSIA
IS EXPLAINED BY
GASTROESOPHAGEAL REFLUX
DISEASE?
Whatever definition of dyspepsia is
used, there is a considerable overlap of
upper gastrointestinal tract symptoms in
the general population. The majority of
patients with upper abdominal symptoms
who are labelled as having non-ulcer dys-
pepsia also have some heartburn [1]. Thus,
Jones and Lydeard in a population-based
survey from the United Kingdom reported
that 56 percent ofsubjects with upper gas-
trointestinal symptoms had both heartburn
and upper abdominal pain (Figure 1) [7],
and these results have been confirmed in
the United States and elsewhere [8-10].
There are surprisingly few data on the dis-
criminant value of heartburn, but it has
been reported that heartburn is an insensi-
tive symptom for the detection oftrue gas-
troesophageal reflux disease. Klauser et al.
found that heartburn had a sensitivity of
only 38 percent for gastroesophageal
reflux disease based on abnormal 24-hour
esophageal pH testing, indicating that
many people with this symptom will not
have the disease [11]. Unfortunately, this
was a flawed study because only very
selected patients were included (namely
those referred for 24-hour pH monitoring);
symptom events were not evaluated in
relation to pH change in the esophagus,
and measurement of symptoms may not
have been optimal.
The value of heartburn in identifying
reflux disease must critically depend on
how it is defined and measured. In arecent
study based on a questionnaire, patients
with a burning sensation in the epigastri-
um or lower retrosternal region that radiat-
ed up towards the neck described their
main symptom as epigastric pain rather
than as heartburn in 56 percent of cases
[12]. Yet aburning sensation in the epigas-
trium or retrosternum that travels up
towards the neck has an excellent positive
predictive value for an abnormal 24-hour
esophageal pH test or the presence of ero-
sive esophagitis, and also is highly predic-
tive of the response to proton pump
inhibitor therapy over placebo [13]. These
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symptom-based definitions of dyspepsia
and heartburn can be more rigorous, and
appropriate history taking may help to dif-
ferentiate reflux from dyspepsia [14], but
the current non-ulcer dyspepsia literature
is contaminated by reflux patients [15, 16].
IS H. PYLORI LINKEDTO
GASTROESOPHAGEAL REFLUX?
The relationship between H. pylori
and gastroesophageal reflux is currently
unclear and has been reviewed recently
elsewhere [17-19]. However, there appears
to be increasing evidence for the follow-
ing. Firstly, H. pylori infection is probably
negatively associated with the presence of
reflux esophagitis, at least in some popula-
tions. Thus, Werdmuller and Loffeld iden-
tified the prevalence ofH. pylori to be sig-
nificantly lower in patients with reflux
esophagitis (34 percent) compared with
patients who had a normal upper
endoscopy (51 percent) [20]. Other studies
have supported these observations [21-23]
although some investigators have failed to
detect a significant difference in the preva-
lence ofH. pylori infection between those
with and without reflux esophagitis [24].
The major limitation of the current litera-
ture is that a number of patients with
endoscopy negative (non-erosive) reflux
disease have presumably been included in
the control groups, which may have con-
founded the detection of a negative rela-
tionship in some studies. These observa-
tions are important, however, because ifH.
pylori is really less common in patients
with true gastroesophageal reflux disease,
then this may account for some ofthe con-
fusion in the dyspepsia literature as
described below.
There is also some evidence that cure
of H. pylori infection in duodenal ulcer
disease may result in an increased inci-
dence ofreflux esophagitis. Thus, a recent
study found that reflux esophagitis devel-
oped in approximately 26 percent of duo-
denal ulcer patients cured of the infection
compared with 13 percent in those with
persistent infection [25]. However, inclu-
sion of adequate control groups has been
lacking and both erosive and non-erosive
changes have been lumped together, which
may have confounded the observations
[17, 25, 26].
Thus, H. pylori infection may protect
against reflux esophagitis in a subset, per-
haps because over the long term a propor-
tion of infected patients have
hypochlorhydria, which may or may not
be related to atrophic gastritis [27-29] or
because raised gastrin levels increase
lower esophageal sphincter pressure [17].
Alternatively, the presence ofthe infection
in the region ofthe gastric cardia may alter
reflex responses that reduce the number of
transient loweresophageal sphincterrelax-
ations [17, 18]. On the other hand, patients
with raised acid secretion from an antral-
predominant infection may potentially be
predisposed to reflux esophagitis [18, 19].
ISTHE PREVALENCE OF
H. PYLORIINCREASED IN
NON-ULCER DYSPEPSIA?
H. pylori infection is present in 40 to
90 percent of patients with non-ulcer dys-
pepsia based on a wide range ofpublished
studies [3-6]. While it has been reported
that the prevalence of infection is higher
than in control groups, appropriate con-
trols have often not been studied adjusting
for factors such as age, socio-economic
status, ethnic background and history of
peptic ulcer disease, which all affect the
prevalence of H. pylori infection. Thus, in
a Dutch study that evaluated otherwise
healthy volunteers, there was an associa-
tion between H. pylori and dyspepsia, but
this disappeared when those with a past
history of ulcer disease were excluded
[30]. A recent meta-analysis has suggested
that there is indeed a two-fold increased
risk ofdyspepsia overall in infected cases,
but this study could not take into account
the quality of the data included [3].
Indeed, how many patients with reflux in
fact were mislabelled as having dyspepsia148 Talley: H. pylori and dyspepsia
50
_No Dyspepsia
dyspepsia
40-
320-
c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
20
10
0-
Figure 2. Prevalence of H. pylori (percent) among the dyspepsia subgroups in
healthy blood donors. Note the similar prevalence in reflux-like dyspepsia compared with
the other subgroups. From Reference [34] with permission.
remains an unknown quantity that may
have variably affected the associations
reported.
IS H. PYLORIA CAUSE OF
SPECIFIC DYSPEPTIC
SYMPTOMS?
A number ofstudies have investigated
whether individual symptoms may be
linked to H. pylori infection. No relation-
ship between heartburn and H. pylori has
been detected in most of the published
studies [3-6]. However, Rosenstock et al.
reported in a random sample of3589 adult
Danish subjects that heartburn was associ-
ated with H. pylori seropositivity [31].
Some studies have detected a link between
other symptoms such as postprandial
bloating [32], orepigastric pain orburning
and H. pylori infection [33], but there is a
total lack of consistency in the literature
suggesting that many if not all of these
associations are spurious [5].
Other studies have divided subjects
with dyspepsia into symptom subgroups in
order to try and detect whether there is a
link between H. pylori and symptoms [34-
36]. While these subgroups have been
variably defined, the studies have univer-
sally failed to detect an association
between reflux-like dyspepsia and H.
pylori [34-36]. Similarly, no association
between ulcer-like ordysmotility-like dys-
pepsia and H. pylori has been identified
(Figure 2) [34, 36].
DOES CURE OF H. PYLORICURE
NON-ULCER DYSPEPSIA?
This remains one of the key ques-
tions, which as yet does not have a clear
answer. A number of studies have investi-
gated the effects of bismuth in non-ulcer
dyspepsia, but the results have been con-
flicting, symptom reduction was variable
and only suppression of infection was
achieved in most cases [37]. A number of
more recent studies have tested the effica-
cy of cure of H. pylori infection [38].
Interpretation of the eradication trials is
difficult as the results have been conflict-
ing [39-45]. Unfortunately, relatively few
studies have been randomized, double-
blind placebo-controlled trials that have
employed adequate follow-up (although
how long follow-up needs to be in order to
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Table 1. Randomized controlled trials of clinical efficacy of H. pylori eradication in
patients with non-ulcer dyspepsia with more than six months follow up (1995-1997).
Placebo Time to
group follow-up
Author Treatment No. Double-blind included (months) Results
van Zanten et al. BSS + AMO + MTZ 53 Yes Yes 6 NS*
1995, [39]
Lazzaroni et al. CBS + MTZ 41 Yes Yes 6 p <.05**
1996 [40] vs. CBS + placebo
Schutze et al. CLR + RAN 54 No No 12 NS**
1996 [41]
Cucchiara et al. CBS + TIN + AMO 64 No No 6 NS**
1996 [42] 1 week vs. 4 weeks
Greenberg et al. CLR + OME 33 Yes Yes 1,3,6,12 NS*
1996 [43]
Sheu et al. CBS + AMO + MTZ 41 No No 6 and 12 p <.01**
1996 [4] vs. H2 blocker
Gilvarry et al. CBS + MTZ + TET 100 Uncertain Yes 2, 6,12 p <.01***
1997 [45] vs. CBS + placebo
BSS, bismuth subsalicylate; MTA, metronidazole; CLR, clarithromycin; RAN, rantitidine;
AMO, amoxycillin; CBS, colloidal bismuth subcitrate; TIN, tinidazole; OME, omeprazole;
NS, not significant; *, comparison between patients with active treatment and placebo; **,
comparison between patients with H. pylori eradicated and those with persistent infection
or with persistent and current infections; ***, comparison between patients with H. pylori
eradicated and those receiving other active therapy.
not well enough defined) (Table 1). It is
also conceivable that a small minority of
patients with non-ulcer dyspepsia may
become worse because reflux symptoms
are induced by H. pylori eradication.
Thus, El-Omar et al. have reported among
hypochlorhydric subjects with body-pre-
dominant H. pylori gastritis that gastric
acid secretion increased in 12 of 15 after
eradication therapy, and six of 15 devel-
oped heartburn [27]. A number of large
well designed randomized controlled tri-
als will be available in the near future,
which hopefully will shed new light in this
confusing area.
REFERENCES
1. Talley, N.J., Colin-Jones, D., Koch, K.L.,
Koch, M., Nyren, O., and Stanghellini, V.
Functional dyspepsia: a classification with
guidelines for diagnosis and management.
Gastroenterol. Int. 4:145-116, 1991.
2. Knill-Jones, R.P. Geographical differences
in the prevalence of dyspepsia. Scand. J.
Gastroenterol. 26(suppl 182):17-24, 1991.
3. Armstrong, D. Helicobacter pylori infec-
tion anddyspepsia. Scand. J. Gastroenterol.
31(suppl 215):38-47, 1996.
4. Lambert, J.R. The role of Helicobacter
pylori in non-ulcer dyspepsia - a debate:
for. Gastroenterol. Clin. N. Am. 22:141-
151, 1993.
5. Talley, N.J. The role ofHelicobacterpylori
in non-ulcer dyspepsia - a debate: against.
Gastroenterol. Clin. N. Am. 22:153-
167,1993.
6. Van zanten, S.J.O.V. The role of
Helicobacter pylori infection in non-ulcer
dyspepsia. Aliment. Pharmacol. Ther.
1l(suppl 1):A63-69, 1997.
7. Jones, R. and Lydeard, S. Prevalence of
symptoms of dyspepsia in the community.
Br. Med. J. 298:30-32, 1989.
8. Talley, N.J., Zinsmeister, A.R., Schleck,
C.D., and Melton, L.J., HI. Dyspepsia and150 Talley: H. pylori and dyspepsia
dyspepsia subgroups: a population-based
study. Gastroenterology 102:1259-1268,
1992.
9. Locke, G.R., Talley, N.J., Fett, S.L.,
Zinsmeister, A.R., and Melton, L.J.
Prevalence and clinical spectrum of gas-
troesophageal reflux- a population-based
study in Olmsted County, Minnesota.
Gastroenterology 112:1448-1456, 1997.
10. Agreus, L., Svardsudd, K., Nyren, O., and
Tibblin, G. Irritable bowel syndrome and
dyspepsia in the general population: over-
lap and lack of stability over time.
Gastroenterology 109:671-680, 1995.
11. Klauser, A.G., Schindlbeck, N.E., and
Muller Lissner, S.A. Symptoms in gastro-
oesophageal reflux disease. Lancet
335:295-298, 1990.
12. Carlsson, R., Dent, J., Glise, H., Riley, S.,
Torfgard, K., and Junghard, 0. Evaluation
of a questionnaire for the diagnosis of
symptomatic gastroesophageal reflux dis-
ease (GERD). Gastroenterology 1 l0:A76,
1996.
13. Carlsson, R., Bolling, E., Jerndal, P.,
Junghard, O., Lauritsen, K., and Glise, H.
Factors predicting response to omeprazole
treatment in patients with functional dys-
pepsia. Gastroenterology 1 10:A76, 1996.
14. Heading, R.C., Wager, E., and Tooley,
P.J.H. Reliability of symptom assessment
in dyspepsia. Eur. J. Gastroenterol.
Hepatol. 9:779-781, 1997.
15. Small, P.K., Loudon, M.A., Waldron, B.,
Smith, D., and Campbell, F.C. Importance
of reflux symptoms in functional dyspep-
sia. Gut 36:189-192, 1995.
16. Pfeiffer, A., Aronbayev, J., Schmidt, T.,
Wendl, B., Pehl, C., and Kaessl, H. Gastric
emptying, esophageal 24-hour pH and gas-
tric potential difference measurements in
non-ulcer dyspepsia. Gastroenterol. Clin.
Biol. 16:395-400, 1992.
17. Labenz, J. and Malfertheiner, P. Helico-
bacter pylori in gastro-oesophageal reflux
disease: causal agent, independent or pro-
tective factor? Gut 41:277-280, 1997.
18. Vicari, J., Falk, G.W., and Richter, J.E.
Helicobacter pylori and acid peptic disor-
ders of the esophagus - is it conceivable?
Am. J. Gastroenterol. 92:1097-1102, 1997.
19. Xia, H.H.X. and Talley, N.J. Helicobacter
pylori infection, reflux esophagitis and
atrophic gastritis: an unexplored triangle.
Am. J. Gastroenterol. (In press)
20. Werdmuller, B.F.M. and Loffeld, R.J.L.F.
Helicobacterpylori infection has no role in
the pathogenesis ofreflux esophagitis. Dig.
Dis. Sci. 42:103-105, 1997.
21. Befrits, R., Granstrom, M., Rylander, M.,
Rubio, C. Helicobacter pylori in 205 con-
secutive endoscopy patients. Scand. J.
Infect. Dis. 25:185-191, 1993.
22. Cheng, E.H., Bermanski, P., Silversmith,
Valenstein, P., and Kawanishi, H.
Prevalence of Campylobacter pylori in
esophagitis, gastritis, and duodenal disease.
Arch. Intern. Med. 149:1373-1375, 1989.
23. Liston, R., Pitt, M.A., and Banerjee, A.K.
Reflux oesophagitis and Helicobacter
pylori infection in elderly patients.
Postgrad. Med. J. 72:221-223, 1996.
24. Newton, M., Bryan, R., Burnham, W.R.,
and Kamm, M.A. Evaluation of
Helicobacter pylori in reflux oesophagitis
and Barrett's oesophagitis. Gut 40:9-13,
1997.
25. Labenz, J., Blum, A.L., Bayerdorffer, E.,
Meining, A., Stolte, M., and Borsch, G.
Curing Helicobacter pylori infection in
patients with duodenal ulcer may provoke
reflux esophagitis. Gastroenterology
112:1442-1447, 1997.
26. Sacca, N., De Medici, A., Rodino, S., and
Giglio, A. Reflux esophagitis: a complica-
tion of Helicobacter pylori (HP) eradica-
tion therapy. Gut 39(suppl 3):A35, 1996.
27. El-Omar, E.M., Oien, K., El-Nuyumi, A.,
Gillen, D., Wirz, A., Dahill, S., Williams,
C., Ardill, J.E.S., and McColl, K.E.L.
Helicobacter pylori infection and chronic
gastric acid hyposecretion. Gastroenterol-
ogy 113: 15-24, 1997.
28. Kuipers, E.J., Lundell, L., Klinkenberg-
Knol, E.C., Havu, N., Festen, H.P.M.,
Liedman, B., Lamers, C.B.H.W., Jansen,
J.B.M.J., Dalenback, J., Snel, P., Nelis,
G.F., and Meuwissen, S.G.M. Atrophic
gastritis and Helicobacter pylori infection
in patients with reflux esophagitis treated
with omeprazole or fundoplication. N.
Engl. J. Med. 334:1018-1022, 1996.
29. Kuipers, E.J., Uyterlande, A.M., Pena,
A.S., Rovsendaal, R., Pals, G., Nelis, G.F.,
Festen, H.P.M., and Meuwissen, S.G.M.
Long-term sequelae of Helicobacter
pylori-associated gastritis. Lancet
345:1525-1528, 1995.
30. Schlemper, R.J., van der Werf, S.D.J.,
Vandenbroucke, J.P., Biemond, I., and
Lamers, C.B.H.W. Non-ulcer dyspepsia in
a Dutch working population and
Helicobacter pylori. Arch. Intern. Med.
155:82-87, 1995.
31. Rosenstock, S., Kay, L., Rosenstock, C.,
Andersen, L.P., Bonnevie, O., and
Jorgensen, T. Relation between
Helicobacterpylori infection and gastroin-
testinal symptoms and syndromes. Gut
41:169-176, 1997.
32. Rokkas, T., Pursey, C., Uzoechina, E.,
Dorrington, L., Simmons, N.A., Filipe,Talley: H. pylori and dyspepsia 151
M.I., and Sladen, G.E. Campylobacter
pylori and non-ulcer dyspepsia. Am. J.
Gastroenterol. 82:1149-1152, 1987.
33. Tucci, A., Corinaldesi, R., Stanghellini, V.,
Tosetti, C., di Febo, G., Paparo, F., Varoli,
O., Paganelli, G., Morselli Labate, A.,
Masci, C., Zoccoli, G., Monetti, N., and
Barbara, L. Helicobacter pylori infection
and gastric function in patients with chron-
ic idiopathic dyspepsia. Gastroenterology
103:768-774, 1992.
34. Holtmann, G., Goebell, H., Holtmann, M.,
andTalley, N.J. Dyspepsia in healthy blood
donors: pattern of symptoms and associa-
tion with Helicobacter pylori. Dig. Dis.
Sci. 39:1090-1098, 1994.
35. Agreus, L., Engstrand, L., Svardsudd, K.,
Nyren, O., and Tibblin, G. Helicobacter
pylori seropositivity among Swedish adults
with and without abdominal symptoms: a
population-based epidemiologic study.
Scand. J. Gastroenterol. 30:752-757, 1995.
36. Nandurkar, S., Talley, N.J., Xia, H.H.-X.,
Patiag, D., Hazel, S., Mitchell, H., and
Jones, M. Dyspepsia in the community is
linked to smoking and aspirin use but not to
Helicobacter pylori. Gastroenterology
112:A232, 1997.
37. Talley, N.J. A critique of therapeutic trials
in Helicobacter pylori-positive functional
dyspepsia. Gastroenterology 106:1174-
1183, 1994.
38. Laheij, R.J.F., Jansen, J.B.M.J., Van Da
Lisnok, E.H., Severens, J.L. and Verbeek,
A.L.M. Review article: symptom improve-
ment through eradication of Helicobacter
pylori in patients with non-ulcer dyspepsia.
Aliment. Pharmacol. Ther. 10:843-850,
1996.
39. Vedhuyzen van Zanten, S.J.0., Malatjilian,
D., Tanton, R., Leddin, D., Hunt, R.H., and
Blanchard, W. The effect oferadication of
H. pylori on symptoms of non-ulcer dys-
pepsia: a randomized double-blind placebo
controlled trial. Gastroenterology
108:A250, 1995.
40. Lazzaroni, M., Bargigga, S., Sangaletti, O.,
Maconi, G., Boldorini, M., and Bianchi
Aporro, G. Eradication of Helicobacter
pylori and long-term outcome offunctional
dyspepsia. A clinical endoscopic study.
Dig. Dis. Sci. 41:1589-1594, 1996.
41. Schutze, K., Hentschel, E., and Hirschl,
A.M. Clarithromycin or amoxycillin plus
high-dose ranitidine in the treatment of
Helicobacter pylori-positive functional
dyspepsia. Eur. J. Gastroenterol. Hepatol.
8:41-46, 1996.
42. Cucchiara, S., Salvia, G., Az-Zeqeh, N.,
D'Armiento, F., DePetra, M.R., Rapagiolo,
S,., Campanozzi, A., and Emiliano, M.
Helicobacterpylori gastritis and non-ulcer
dyspepsia in childhood: efficacy of one-
week triple antimicrobial therapy in eradi-
cating the organism. Ital. J. Gastroenterol.
28:430-435, 1996.
43. Greenberg, P.D. and Cello, J.P. Prospective,
double-blind treatment of Helicobacter
pylori in patients with non-ulcer dyspepsia.
Gastroenterology 11O:A123, 1996.
44. Sheu, B-S., Lin, C-Y., Lin, X-Z., Shiesh, S-
C., Yang, H-B., and Chen, C-Y. Long-term
outcome oftriple therapy inH. pylori-relat-
ed non-ulcer dyspepsia: a prospective con-
trolled assessment. Am. J. Gastroenterol.
91:441-447, 1996.
45. Gilvarry, J., Buckley, M., Beattie,
Hamilton, H., and O'Morain, C.
Eradication of Helicobacter pylori affects
symptoms in non-ulcerdyspepsia. Scand. J.
Gastroenterol. 32:535-540, 1997.